Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Risdiplam Exchange in SMA (RISE)
NCT05522361Phase 4Active, not recruiting
- Sponsor
- Clinic for Special Children
- Start
- Nov 2022
- Primary completion
- Dec 2025
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of risdiplam in spinal muscular atrophy (SMA), sponsored by Clinic for Special Children. Started Nov 2022; status: active, not recruiting.
02
Drugs
risdiplam
03
Conditions
spinal muscular atrophy (SMA)
Beyond the preview
Go deeper on NCT05522361.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05522361.